Top

Reactions Weekly

Published in:

01-07-2023 | Methotrexate | Case report

Antineoplastics

Lymphoproliferative disorders and lack of efficacy: 36 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Gion Y, et al. PD-L1 expression is associated with the spontaneous regression of patients with methotrexate-associated lymphoproliferative disorders. Cancer Medicine 11 : 417-432, No. 2, Jan 2022. Available from: URL: http://doi.org/10.1002/cam4.4462

Title: Antineoplastics
Lymphoproliferative disorders and lack of efficacy: 36 case reports
Publication date: 01-07-2023
Publisher: Springer International Publishing
Keywords: Methotrexate
Methotrexate
Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Sodium Aurothiomalate
Rheumatoid Arthritis
Psoriatic Arthritis
Scleroderma
Thyroiditis
Etanercept
Adalimumab
Infliximab
Rituximab
Rituximab
Cytostatic Therapy
Prednisolone
Tacrolimus
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-43508-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastics

Lymphoproliferative disorders and lack of efficacy: 36 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Immediate ADRs after COVID-19 vaccination in Denmark

Monoclonal-antibody-3f8/naxitamab

Semaglutide, liraglutide: risk of suicidal ideation and self-injury

Insulin-glargine/insulin-lispro

Multiple drugs